Osteosarcoma — Trials

Osteosarcoma — Trials · CancerIndex

Clinical trials

Registered studies

349 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 99
Recruiting: 58
Ph III recruiting: 2
Growth YoY: —
Industry share: 14%
Top sponsor: National Cancer Institute (NCI)
Termination share: 33.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (40)

clinicaltrialsPublishedShowing 151–162 of 162 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00091182	Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment	completed	Phase 2	180	National Cancer Institute (NCI)NIH	1	Jun 5, 2013	clinicaltrials
NCT00889057	Sorafenib in Relapsed High Grade Osteosarcoma	completed	Phase 2	35	Italian Sarcoma GroupNETWORK	1	Mar 28, 2013	clinicaltrials